The present disclosure relates to a composition comprising sesamol and epigallocatechin gallate, the combination of which, at particular w/w ratios allows for enhancement of the ability of cells to take up extracellular glucose. These findings are potentially useful in formulating recipes which seek to control blood sugar levels in people with compromised blood sugar absorption mechanisms.